Healthcare technology company MIMS expands artificial intelligence data platform
Medical data firm MIMS introduced artificial intelligence capabilities and new digital healthcare tools to accelerate international operations across regional markets
Media OutReach Newswire reports that Singapore-based MIMS Group, an Asia-Pacific leader in medicines information and clinical decision support, is accelerating technology-driven growth. Since appointing Sohil Goswami as Group CEO in January 2026, MIMS has restructured its businesses and leadership to create scalable products and new business models across markets.
The company recently launched MIMS Pulse, a next-generation Clinical Decision Support platform that leverages its extensive medicines data and clinical knowledge with modern technology, flexible deployment, and integration capabilities. Additionally, MIMS is scaling eMIMS Plus, a platform that brings trusted medicines information into a modern digital experience, now available in India and Malaysia with expansion plans across Southeast Asia.
MIMS Medical Communications business is also expanding globally, focusing on digital events, AI-enabled content capabilities, and new customer engagement models. Goswami emphasized that MIMS is transforming its foundation into next-generation digital products and services to serve customers across markets more effectively.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
